中国临床肿瘤学年度研究进展2015 recurrent gastric cancer. Gastric Cancer, 2016. 19: 234-244 23. Hu XC, Zhang J, Xu BH, et al. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-lir therapy for metastatic triple-negative breast cancer( CBCSGo06 ) a randomised, open-label, multicentre phase 3 trial. Lancet Oncol, 2015. 16: 436-446 24. Wei wQ, Chen ZF, He YT, et al. Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic sophageal Cancer in China. J Clin Oncol, 2015, 33: 1951-1957 25. Huang H, Li X, Zhu J, et al. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy a randomized clinical trial.JAMA,2014,312:2521-2530 26. Shi Y, Dong M, Hong X, et al. Results from a multicenter, open-label, pivotal phase II study of chidamide lapsed or refractory peripheral T-cell lymphoma. Ann Oncol, 2015, 26: 1766-1 27. Xu X, Lu D, Ling Q.et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut 28. Ren Z, Zhu K, Kang H, et al. Randomized controlled trial of the prophylactic effect of urea-based sorafenibr-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. J Clin Oncol 015,33:894-90011 中国临床肿瘤学年度研究进展 2015 recurrent gastric cancer. Gastric Cancer，2016，19：234-244. 23. Hu XC，Zhang J，Xu BH，et al. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer （CBCSG006）：a randomised，open-label，multicentre，phase 3 trial. Lancet Oncol，2015，16：436-446. 24. Wei WQ，Chen ZF，He YT，et al. Long-Term Follow-Up of a Community Assignment，One-Time Endoscopic Screening Study of Esophageal Cancer in China. J Clin Oncol，2015，33：1951-1957. 25. Huang H，Li X，Zhu J，et al. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy：a randomized clinical trial. JAMA，2014，312：2521-2530. 26. Shi Y，Dong M，Hong X，et al. Results from a multicenter，open-label，pivotal phase Ⅱ study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann Oncol，2015，26：1766-1771. 27. Xu X，Lu D，Ling Q，et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut， 2015. 28. Ren Z，Zhu K，Kang H，et al. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. J Clin Oncol， 2015，33：894-900